TickerFacts.

Avantor, Inc. (AVTR): Cost of Revenue

Annual figures by period end, from SEC filings.

$4.41B
Year ended 2025-12-31
$4.45B
Trailing 12 months to 2026-03-31
-3.5%
3-year compound annual growth
+0.5%
5-year compound annual growth
$4.91B2017-12-31: $814.60M2018-12-31: $4.04B2019-12-31: $4.12B2020-12-31: $4.31B2021-12-31: $4.88B2022-12-31: $4.91B2023-12-31: $4.60B2024-12-31: $4.50B2025-12-31: $4.41B$4.41B
2017-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$4.41B-2.0%2026-02-11, From 2025-01-01
2024-12-31$4.50B-2.2%2026-02-11, From 2024-01-01
2023-12-31$4.60B-6.2%2026-02-11, From 2023-01-01
2022-12-31$4.91B+0.5%2025-02-07, From 2022-01-01
2021-12-31$4.88B+13.2%2024-02-14, From 2021-01-01
2020-12-31$4.31B+4.7%2023-02-14, From 2020-01-01
2019-12-31$4.12B+1.9%2022-02-11, From 2019-01-01
2018-12-31$4.04B+396.5%2021-02-16, From 2018-01-01
2017-12-31$814.60Mn/a2020-02-14, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Avantor, Inc. (AVTR)2025-12-31$4.41B-2.0%
Agilent Technologies, Inc. (A)2025-10-31$3.31B+11.1%
Illumina, Inc. (ILMN)2025-12-28$1.47B-2.5%
Bruker Corp (BRKR)2025-12-31$1.86B+8.3%
Waters Corp (WAT)2025-12-31$1.29B+7.4%
Bio-Rad Laboratories, Inc. (BIO)2025-12-31$1.24B+4.7%
10x Genomics, Inc. (TXG)2025-12-31$198.94M+1.3%
Cytek Biosciences, Inc. (CTKB)2025-12-31$97.03M+8.6%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$114.22M-2.1%

Compare AVTR, A, ILMN, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗